BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
8.80
+0.01 (0.11%)
At close: Apr 28, 2026, 4:00 PM EDT
8.97
+0.17 (1.93%)
After-hours: Apr 28, 2026, 6:08 PM EDT

BBOT Statistics

Total Valuation

BBOT has a market cap or net worth of $704.29 million. The enterprise value is $283.20 million.

Market Cap 704.29M
Enterprise Value 283.20M

Important Dates

The next estimated earnings date is Tuesday, May 26, 2026, before market open.

Earnings Date May 26, 2026
Ex-Dividend Date n/a

Share Statistics

BBOT has 80.03 million shares outstanding. The number of shares has increased by 241,276.23% in one year.

Current Share Class 80.03M
Shares Outstanding 80.03M
Shares Change (YoY) +241,276.23%
Shares Change (QoQ) +83.92%
Owned by Insiders (%) 5.66%
Owned by Institutions (%) 40.77%
Float 31.16M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 1.71
P/TBV Ratio 1.72
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 12.34, with a Debt / Equity ratio of 0.01.

Current Ratio 12.34
Quick Ratio 12.15
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -48.23% and return on invested capital (ROIC) is -32.63%.

Return on Equity (ROE) -48.23%
Return on Assets (ROA) -29.75%
Return on Invested Capital (ROIC) -32.63%
Return on Capital Employed (ROCE) -35.28%
Weighted Average Cost of Capital (WACC) 7.02%
Revenue Per Employee n/a
Profits Per Employee -$1.46M
Employee Count 92
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -20.07% in the last 52 weeks. The beta is 0.51, so BBOT's price volatility has been lower than the market average.

Beta (5Y) 0.51
52-Week Price Change -20.07%
50-Day Moving Average 9.39
200-Day Moving Average 10.91
Relative Strength Index (RSI) 44.53
Average Volume (20 Days) 493,950

Short Selling Information

The latest short interest is 3.24 million, so 4.04% of the outstanding shares have been sold short.

Short Interest 3.24M
Short Previous Month 2.39M
Short % of Shares Out 4.04%
Short % of Float 10.39%
Short Ratio (days to cover) 11.78

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -145.82M
Pretax Income -134.04M
Net Income -134.04M
EBITDA -145.54M
EBIT -145.82M
Earnings Per Share (EPS) -$4.30
Full Income Statement

Balance Sheet

The company has $425.46 million in cash and $2.77 million in debt, giving a net cash position of $422.69 million or $5.28 per share.

Cash & Cash Equivalents 425.46M
Total Debt 2.77M
Net Cash 422.69M
Net Cash Per Share $5.28
Equity (Book Value) 411.10M
Book Value Per Share 5.14
Working Capital 397.36M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$113.89 million and capital expenditures -$606,000, giving a free cash flow of -$114.50 million.

Operating Cash Flow -113.89M
Capital Expenditures -606,000
Depreciation & Amortization 280,000
Net Borrowing n/a
Free Cash Flow -114.50M
FCF Per Share -$1.43
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

BBOT does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -241,276.23%
Shareholder Yield -241,276.23%
Earnings Yield -18.99%
FCF Yield -16.22%

Analyst Forecast

The average price target for BBOT is $24.00, which is 172.73% higher than the current price. The consensus rating is "Strong Buy".

Price Target $24.00
Price Target Difference 172.73%
Analyst Consensus Strong Buy
Analyst Count 7
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2